Strata Critical Medical, Inc. (SRTA) stock analysis
Healthcare · Medical Care Facilities
From the 10-K filed 2026-03-03
What protects it: the moat
It relies on brand reputation and operational integration to maintain its position within the complex organ transplant ecosystem.
Management claims that its integrated services and reliability allow it to retain relationships with hospital clients and specialized medical staff, which acts as a barrier to new entrants.
About Strata Critical Medical, Inc.
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.